Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,381

Document Document Title
WO/2019/158615A1
The present invention relates to novel lignin-derived compounds and compositions comprising the same and their use as redox flow battery electrolytes. The invention further provides a method for preparing said compounds and compositions ...  
WO/2019/157437A1
We disclose quinone compounds and related species (Formula I) that possess significant advantages when used as a redox active material in a battery, e.g., a redox flow battery. In particular, the compounds provide redox flow batteries (R...  
WO/2019/157163A1
[(2E)-2-[(3-methoxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)met hylidene]-N,N-diethylpentanamide] (APX2009) and (2E)-2-[(3-methoxy-1,4-dioxo-1,4-dihydronapthalen -2-yl)methylidene]-N-methoxypentanamide] (APX2014) for inhibiting ocular disea...  
WO/2019/148282A1
The present disclosure concerns methods and formulations for delivery of hydrophobic agents (such as ubiquinone or poorly soluble drugs) for therapeutic and bioanalytical use. It further concerns use of lipopeptides (e.g. caspofungin) or...  
WO/2019/128060A1
The present application relates to a method for extracting a coenzyme Q10 and phospholipids from a coenzyme Q10 fermentation bacterial powder. The method is characterized in that a mixed solvent having a three-dimensional Hansen solubili...  
WO/2019/123144A1
The present invention provides the use of vitamin K2 compositions for the treatment of drug- induced neuropathy. More particularly it is related to the use of vitamin K2-7 compositions for the treatment of drug- induced peripheral neurop...  
WO/2019/071353A1
A method of reducing glutamate efflux from skeletal muscle by inhibiting system Xc- activity is provided. The method is useful for the treatment of statin-induced myalgia. Pharmaceutical compositions useful to treat statin-induced myalgi...  
WO/2019/052477A1
Provided is the use of a class of tanshinone compounds for treating hemangioma; in particular, provided is the use of a class of compounds as shown in formula I below or a pharmaceutically acceptable salt thereof. The tanshinone compound...  
WO/2019/028933A1
The present invention relates to the technical field of pharmaceuticals, and discloses an antibacterial application of a Dryopteris fragrans phloroglucinol compound flavaspidic acid BB. The present invention provides for the first time a...  
WO/2019/009157A1
[Problem] Conventional polymerization inhibitors are used to capture radicals generated, for example, during storage of a radical polymerizable compound, thus allowing the radical polymerizable compound to be safely handled. However, the...  
WO/2018/214814A1
A use of an aminomethylenecyclohexane-1,3-dione compound. In particular, the present invention relates to a use of a compound shown in the following formula (I) or a pharmaceutically acceptable salt thereof alone or in combination with o...  
WO/2018/191789A1
The invention relates to compounds of Formula (I) and methods for their preparation. Also described are pharmaceutical compositions comprising a compound of Formula (I) and their use in the treatment or prevention of conditions associate...  
WO/2018/161482A1
A carbon nitride-based photocatalyst and a preparation method therefor, wherein the photocatalyst is prepared by reacting melcimide with 3,3,,4,4, ­­­­­­­benzophenone tetracarboxylic dianhydride, such that the energy levels of the...  
WO/2018/145660A1
The present invention relates to a fully continuous flow synthesis process for use with 2-methyl-1,4-naphthoquinone and an integrated continuous flow reactor for use in achieving said process; the synthesis process uses 2-methylnaphthale...  
WO/2018/136266A1
Compositions for use in treating and/or alleviating a symptom of inflammatory bowel disease, colitis, and/or enterocolitis in a subject in need thereof are disclosed. The composition comprises a therapeutically effective amount of an ant...  
WO/2018/130865A1
A composition for treating headaches and migraines and methods of using same for preventative use to decrease the frequency, duration and severity of headaches and migraines in children and adults.  
WO/2018/062193A1
Provided is a monomer composition in which the polymerization inhibitor solubility in ring-structured monomer is excellent, the ring-structured monomer stability during storage is excellent, and the ring-structured monomer may be easily ...  
WO/2018/045424A1
The invention relates to terpenes and uses thereof.  
WO/2018/044150A1
The present invention relates to a method for producing demethylbelamcandaquinone B from Labisia pumila and use thereof. The method is characterized by the steps of obtaining an extract from Labisia pumila plant material using water extr...  
WO/2018/007198A1
The present invention relates to the preparation of Thapsigargin (1) and Nortrilobolide (2). The invention further relates to intermediates and preparation of said intermediates which are useful for the preparation of (1) and (2).  
WO/2017/222996A1
Provided herein are compounds, compositions and method of using thereof to treat or prevent malaria.  
WO/2017/193986A1
The present invention relates to a benzyl bisphenol derivative, and a preparation method and pharmaceutical application thereof. The benzyl bisphenol derivative provided by the invention can promote a sedative-hypnotic effect, offer brai...  
WO/2017/151111A1
Improved systems and methods for producing synthetic hypericin at high volume and high purity.  
WO/2017/145814A1
This quinone derivative is a compound represented by general formula (1). In general formula (1), R represents an optionally substituted alkyl group having 1-6 carbon atoms, an optionally substituted aryl group having 6-14 carbon atoms, ...  
WO/2017/145759A1
Provided is a quinone derivative represented by general formula (1). In general formula (1), R1 represents a group selected from the group consisting of an optionally substituted alkyl group having 1-8 carbon atoms, an aryl group that ha...  
WO/2017/145716A1
In this production method according to the present disclosure, a 1,1'-binaphthyl derivative precursor having, at each of the 2-position and 2'-position of a 1,1'-binaphthyl skeleton, an electron-donating group including an oxygen atom di...  
WO/2017/105682A1
A phenylene ether oligomer is prepared by a process that includes partially converting 2,6-dimethylphenol to 3,3',5,5'-tetramethyl-4,4'-dihydroxybiphenyl and/or 3,3',5,5'-tetramethyldiphenoquinone, converting the residual 2,6 dimethylphe...  
WO/2017/106624A1
Provided herein are naphthoquinones compounds such as those with a hydrogen bond donating group of the formula (I): wherein: R1, R2, R3, R4, R5, and n are as defined herein. Also provided herein are pharmaceutical composition of the pres...  
WO/2017/106803A1
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...  
WO/2017/099210A1
The present invention addresses the problem of providing a novel nuclear factor κB (NF-κB) inhibitor. An NF-κB inhibitor that comprises, as an active ingredient, a naphthoquinone compound represented by general formula (1) or a pharma...  
WO/2017/098518A1
A sensing element comprises a transistor having a gate electrode, a source electrode, a gate electrode and a semiconductor nanostructure connecting between the source and the gate electrodes. The semiconductor nanostructure is modified b...  
WO/2017/087576A1
The invention provides methods and compositions for treatment of a subject with a glioma that has failed treatment with temozolomide (TMZ) comprising administration of a composition comprising a Coenzyme Q10 compound to the subject. The ...  
WO/2017/036436A1
The present invention provides primin derivatives of general formula II and/or III, wherein R1 is selected from the group consisting of methyl and hydrogen, R2 is selected from the group consisting of methoxy, hydroxy, hydrogen, R3 is se...  
WO/2017/033557A1
Provided is a method for producing a large amount of 2-hydroxy-1,4-naphthoquinone with a high yield and at a low cost. This method comprises oxidizing 2-hydroxynaphthalene with hydrogen peroxide water in the presence of a vanadium cataly...  
WO/2017/020030A1
The invention relates to new compounds with low cytotoxicity for blocking ubiquitination- proteasome system in diseases. Accordingly, these compounds can be used in treatment of treating disorders including, but not limited to, cancers, ...  
WO/2016/207252A1
A method of preparing a compound represented by general formula (3) : Formula (3). R1 and R2 are each independently an alkyl group. The method includes reacting a compound represented by general formula (2) : Formula (2) with an alkylami...  
WO/2016/201852A1
Provided are a photoreaction device and a system for preparing a compound. The photoreaction device comprises a reaction vessel (100) and a light source (400), wherein the reaction vessel (100) defines a photoreaction space (200), and th...  
WO/2016/199789A1
The present invention addresses the problem of efficiently synthesizing a trifluoromethyl substituted semisquarate in a short process, in order to manufacture trifluoromethyl compounds with various functionalities. A method was developed...  
WO/2016/191872A1
Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) through the administration of a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) antagonist. Also...  
WO/2016/144782A1
Substantially homogeneous and stable suspensions of anthraquinone (AQ) compositions and methods of preparation are disclosed. The AQ compositions are utilized in pulping processes.  
WO/2016/094554A1
2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD), as well as variants, derivatives, analogs, modifications, and conjugates thereof, are identified as therapeutic agents for treating or preventing human cancers and precancerous con...  
WO/2016/060670A1
This invention discloses a method of making vitamin K1. The mentioned method of making vitamin K1 comprises performing a first one-pot synthesis with base catalyst, performing a first hydrolysis, performing a substitution, and performing...  
WO/2016/038146A1
The present invention relates to a new crystal form of ubidecarenone, wherein the ratio of the crystal surface area measured in µm2 per volume measured in µm3 of the ubidecarenone crystals is greater than 2 and wherein the crystal form...  
WO/2016/024145A1
The present invention describes thymoquinone compounds formula ( I ) : (i) These compounds have been identified as being useful in the treatment of cancer.  
WO/2015/192324A1
An anthraquinone compound which is suitable for forming a color filter used for a liquid crystal display device, acomposition containing a resin and the anthraquinone compound, an article having a polymer layer formed from the compositio...  
WO/2015/181283A1
A composition comprising a compound of formula (Va) wherein n is 1 or 2 and wherein m is 1 or 2, with n and m preferably both being 1 or both being 2, more preferably both being 1, and/or, preferably and, a compound of formula, wherein n...  
WO/2015/181297A1
The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene- 9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the pre...  
WO/2015/172076A1
Provided herein are compounds of (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, and prodrugs thereof. Also provided are pharmaceutical compositions and methods involving...  
WO/2015/171589A1
The disclosure relates to BH4 inhibitors and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering therapeutically effe...  
WO/2015/169898A1
The present invention relates to an improved process for the production of 2,6-dimethylbenzoquinone (2,6-DMQ) by oxidation of 2,6-dimethylphenol with oxygen in the presence of a copper salt.  

Matches 1 - 50 out of 2,381